MedWatch

WHO gives further support to Bavarian Nordic and Johnson & Johnson's Ebola vaccine

A WHO committee has updated its recommendations with good news for Johnson & Johnson and Bavarian Nordic's two-dose Ebola vaccine.

Photo: Mads Nissen/STF

The latest recommendations from the World Health Organization (WHO) support the use of Johnson & Johnson and Bavarian Nordic's two-dose vaccine regimen against Ebola virus, according to a Monday press release.

WHO's Strategic Advisory Group of Experts on Immunization (SAGE) has extended its support for the vaccine.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs